Protein Information

ID 4229
Name LANCL2
Synonyms G protein coupled receptor 69B; GPR69B; LANCL 2; LANCL2; LanC (bacterial lantibiotic synthetase component C) like 2; LanC lantibiotic synthetase component C like 2; LanC lantibiotic synthetase component C like 2 (bacterial); LanC like protein 2…

Compound Information

ID 1715
Name abscisic acid
CAS

Reference

PubMed Abstract RScore(About this table)
19667068 Sturla L, Fresia C, Guida L, Bruzzone S, Scarfi S, Usai C, Fruscione F, Magnone M, Millo E, Basile G, Grozio A, Jacchetti E, Allegretti M, De Flora A, Zocchi E: LANCL2 is necessary for abscisic acid binding and signaling in human granulocytes and in rat insulinoma cells. J Biol Chem. 2009 Oct 9;284(41):28045-57. Epub 2009 Aug 10.
Abscisic acid (ABA) is a plant hormone regulating fundamental physiological functions in plants, such as response to abiotic stress. Recently, ABA was shown to be produced and released by human granulocytes, by insulin-producing rat insulinoma cells, and by human and murine pancreatic beta cells. ABA autocrinally stimulates the functional activities specific for each cell type through a receptor-operated signal transduction pathway, sequentially involving a pertussis toxin-sensitive receptor/G-protein complex, cAMP, CD38-produced cADP-ribose and intracellular calcium. Here we show that the lanthionine synthetase C-like protein LANCL2 is required for ABA binding on the membrane of human granulocytes and that LANCL2 is necessary for transduction of the ABA signal into the cell-specific functional responses in granulocytes and in rat insulinoma cells. Co-expression of LANCL2 and CD38 in the human HeLa cell line reproduces the ABA-signaling pathway. Results obtained with granulocytes and CD38 (+)/LANCL2 (+) HeLa transfected with a chimeric G-protein (G alpha (q/i)) suggest that the pertussis toxin-sensitive G-protein coupled to LANCL2 is a G (i). Identification of LANCL2 as a critical component of the ABA-sensing protein complex will enable the screening of synthetic ABA antagonists as prospective new anti-inflammatory and anti-diabetic agents.
35(0,1,1,5)